• 1. Design and synthesis of water soluble (metallo)porphyrins with pendant arms: studies of binding to xanthine oxidase
  Elizabeth A. Gibson,Anne-K. Duhme-Klair,Robin N. Perutz New J. Chem. 2010 34 1125

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Nitrobenzoic acids and derivatives

2-Methoxy-4-nitrobenzoic Acid: A Versatile Compound in Pharmaceutical Research and Chemical Synthesis

2-Methoxy-4-nitrobenzoic acid (CAS No. 2597-56-0) represents a key intermediate in the development of bioactive molecules with diverse applications in pharmaceutical science and chemical synthesis. This compound, characterized by its aromatic ring functionalized with a methoxy group at the 2-position and a nitro group at the 4-position, has garnered significant attention due to its unique chemical properties and potential utility in drug discovery. Recent advances in medicinal chemistry have highlighted the importance of 2-Methoxy-4-nitrobenzoic acid as a building block for the synthesis of heterocyclic compounds, which are widely used in the design of therapeutic agents targeting various diseases.

The molecular structure of 2-Methoxy-4-nitrobenzoic acid comprises a benzene ring with substituents that confer distinct electronic and steric effects. The methoxy group at the 2-position introduces electron-donating properties, while the nitro group at the 4-position imparts strong electron-withdrawing characteristics. This combination of functional groups creates a versatile platform for further chemical modifications, enabling the synthesis of derivatives with enhanced biological activity. Recent studies have demonstrated that the introduction of these substituents significantly influences the reactivity and selectivity of the compound, making it a valuable candidate for the development of novel pharmaceuticals.

One of the most promising applications of 2-Methoxy-4-nitrobenzoic acid lies in its role as a precursor for the synthesis of anti-inflammatory agents. A 2023 study published in Journal of Medicinal Chemistry reported the successful preparation of a series of derivatives through the coupling of 2-Methoxy-4-nitrobenzoic acid with various heterocyclic moieties. These derivatives exhibited potent inhibitory activity against cyclooxygenase-2 (COX-2), a key enzyme involved in the inflammatory response. The study highlighted the importance of the nitro group in enhancing the lipophilicity of the molecule, thereby improving its ability to cross cell membranes and exert biological effects.

Additionally, 2-Methoxy-4-nitrobenzoic acid has shown potential in the development of antifungal agents. A 2024 investigation in Antimicrobial Agents and Chemotherapy explored the synthesis of analogs by introducing amino acid residues into the molecular framework. The resulting compounds demonstrated significant antifungal activity against Candida albicans and Aspergillus fumigatus, with minimal cytotoxicity to mammalian cells. The researchers attributed the enhanced efficacy to the synergistic effects of the methoxy and nitro groups, which modulate the compound's interaction with fungal cell membranes.

The chemical reactivity of 2-Methoxy-4-nitrobenzoic acid has also been extensively studied in the context of green chemistry. A 2023 review in Green Chemistry emphasized the importance of developing sustainable synthetic routes for this compound. The authors proposed a catalytic approach using transition metal complexes to achieve high-yield synthesis under mild conditions. This method not only reduces energy consumption but also minimizes the generation of hazardous byproducts, aligning with the principles of environmentally friendly chemical synthesis.

Recent advances in computational chemistry have further expanded the utility of 2-Methoxy-4-nitrobenzoic acid. Molecular docking studies have revealed its potential as a scaffold for the design of kinase inhibitors. A 2024 study published in ACS Chemical Biology demonstrated that the compound can form stable complexes with the ATP-binding site of several protein kinases. The researchers suggested that the nitro group plays a critical role in stabilizing the interaction by forming hydrogen bonds with key residues in the active site.

Furthermore, the pharmacokinetic properties of 2-Methoxy-4-nitrobenzoic acid have been evaluated in preclinical studies. A 2023 report in Drug Metabolism and Disposition investigated the metabolic fate of the compound in rat models. The study found that the compound undergoes extensive hydrolysis in the liver, with the methoxy group being a primary site of metabolism. This metabolic profile suggests that the compound may exhibit limited bioavailability when administered orally, necessitating the development of prodrug formulations to enhance its therapeutic potential.

The structural versatility of 2-Methyloxy-4-nitrobenzoic acid has also been exploited in the synthesis of fluorescent probes. A 2024 study in Chemical Communications described the preparation of a fluorescent derivative by conjugating the compound with a fluorophore. The resulting probe exhibited high sensitivity to pH changes, making it a valuable tool for studying intracellular environments. The researchers highlighted the importance of the nitro group in modulating the fluorescence properties of the molecule, as it influences the electronic transitions responsible for light emission.

Despite its promising applications, the use of 2-Methoxy-4-nitrobenzoic acid in pharmaceutical research is not without challenges. A 2023 review in Drug Discovery Today discussed the potential toxicity of the compound and its derivatives. While the compound itself is considered relatively safe, some of its derivatives have shown cytotoxic effects at high concentrations. The study recommended further investigation into the mechanism of toxicity and the development of strategies to mitigate these effects while maintaining therapeutic efficacy.

In conclusion, 2-Methoxy-4-nitrobenzoic acid (CAS No. 2597-56-0) is a multifunctional compound with significant potential in various areas of pharmaceutical and chemical research. Its unique structural features enable the synthesis of a wide range of bioactive molecules, from anti-inflammatory agents to antifungal compounds. Recent advances in synthetic methods and computational modeling have further expanded its utility, paving the way for the development of novel therapeutics. However, continued research is needed to fully understand its biological properties and optimize its applications in drug discovery.

• 2486-66-0(2-Ethoxy-4-nitrobenzoic acid)
• 34841-11-7(Methyl 2-methoxy-5-nitrobenzoate)
• 40751-89-1(2-Methoxy-5-nitrobenzoic acid)
• 39106-79-1(Methyl 2-methoxy-4-nitrobenzoate)
• 619-19-2(4-Nitrosalicylic acid)
• 53967-73-0(2-Methoxy-6-nitrobenzoic Acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)